ADORA2A and renal cell carcinoma: Regarding the adenosine pathway in RCC, studies have shown that high CD73 expression correlates with poor prognosis [17] and that the ADORA2A (A2AR) and NT5E (CD73) genes are both highly expressed in the disease [18].